3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Terminated
1
Sponsor Class
OTHER
22
NIH
2
OTHER_GOV
1
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Lymphoma, Mantle-Cell
1
Interventions
Rituximab
8
Vincristine
5
Doxorubicin
5
Cyclophosphamide
5
Methotrexate
4
Cytarabine
4
Bortezomib
4
Radiotherapy
3
Prednisone
3
Bendamustine Hydrochloride
3
Peripheral Blood Stem Cell Transplantation
2
Melphalan
2
Leucovorin
2
Dexamethasone
2
CT-P10
2
zanubrutinib
1
obinutuzumab
1
merphos
1
liposomal amphotericin B
1
ixabepilone
1
ibritumomab tiuxetan
1
fludarabine phosphate
1
carmustine, poliferprosan 20 drug combination
1
alvocidib
1
acalabrutinib
1
Whole-Body Irradiation
1
Watchful Waiting
1
Vancomycin
1
Tazobactam
1
Tacrolimus
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
NETWORK
×
Lymphoma, Mantle-Cell
×
obinutuzumab
×
Clear all
NCT03229382
2023-08-16
OPERA-PLRG10
Polish Lymphoma Research Group
Phase 2
Terminated
1 enrolled